This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 22 Sep 2015  |  North America  |  Market Research

    New Product Innovation Leadership - Value Based Care Administration System - GE Centricity Financial Risk Manager

    A Frost & Sullivan Position Paper

    Healthcare information technology systems to support provider financial management is a key area of growth and interest in the market. With shifts in models to value-based payments (VBR), this entails more financial risk for providers. Successful management of the transition to VBR can only be achieved when healthcare organizations are clinically a...

    $1,500.00
  2. 21 Sep 2015  |  North America  |  Market Research

    Vital Signs - Review of AHRA 2015: Key Conference Takeaways and Gadolinium Based MR Contrast Agents Safety Issues

    Overview of Top Themes from the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA)

    A record-high attendance of 1,000 radiology directors and managers convened to the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA 2015) held this year in Las Vegas. Radiology is going through interesting times indeed. Under the coordinated care paradigm that is gradually emerging in the U.S., and with all the changes th...

    $450.00
  3. 20 Sep 2015  |  North America  |  Market Research

    Strategic Overview of Patenting Activity in Pharma Sector of BRIC Countries

    Patenting Trends, IP Policy Developments, and Strategic Insights

    Since the introduction of Lucentis in 2006, vascular endothelial growth factor (VEGF) antagonists have become the clear choice in treatment for age related macular degeneration, diabetic macular edema, and retinal vein occlusion due to their high efficacy and safety. This research service evaluates the US market for the pharmaceutical management o...

    $4,950.00
  4. 15 Sep 2015  |  North America  |  Market Research

    Development of Value-based Imaging

    Driving Vendor-Customer Relationships in a Value-focused Medical Imaging Environment in the United States

    A trickle-down effect from healthcare reform, together with a transformation operated from within, is pushing the medical imaging industry into a value-focused environment. Although it does seem that the volume-to-value transition in medical imaging will be more of a gradual process than an overnight change, it is already well underway. Its impact ...

    $2,450.00
  5. 09 Sep 2015  |  North America  |  Market Research

    Product and Pipeline Analysis of the Global Colorectal Cancer Market

    Targeted Therapeutics and Immunology Combine to Take Colorectal Cancer Treatments to the Next Level

    This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...

    $3,950.00
  6. 07 Sep 2015  |  North America  |  Market Research

    US Nucleic Acid Purification and Isolation Markets

    Critical Sample Preparation Step Benefits from Downstream Applications

    The total market, as defined by this study, includes nucleic acid purification and isolation reagents (including kits and homebrew reagents) and nucleic acid purification and isolation instruments in the United States. The study period runs from 2011 to 2021, with 2014 as the base year and 2015–2021 as the forecast period. This research service o...

    $4,950.00
  7. Sample preparation remains one of the largest headaches and bottlenecks in research, but is crucial to the success of downstream applications. While the market lacks the hype and excitement other hot technologies, the sample preparation market will always be a slow and steady gainer on an already large market size. Automation and application trends...

    $450.00
  8. 03 Sep 2015  |  Asia Pacific  |  Market Research

    Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020

    Policies Raising Standards and Lowering Barriers Across ASEAN

    The research service provides an analysis of the policies impacting the healthcare market in the Association of Southeast Asian Nations (ASEAN). It includes the current trends, market size, revenue forecast, and market drivers and restraints. Healthcare market participants and key opinion leaders were interviewed to obtain their perception about tr...

    $2,450.00
  9. 02 Sep 2015  |  Asia Pacific  |  Market Research

    Analysis of the Global Human Albumin Market and Product Pipeline

    Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities

    The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

    $4,950.00
  10. 02 Sep 2015  |  Global  |  Market Research

    The New Age of Regenerative Medicine

    Why Stem Cell Therapy?

    Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...

    $1,500.00